• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Discovery of diagonositc and therapeutic biomarker by circulating tumor endothelial cells in metastatic renal cell carcinoma

Research Project

Project/Area Number 23592320
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Urology
Research InstitutionHokkaido University

Principal Investigator

SHINOHARA Nobuo  北海道大学, 医学(系)研究科(研究院), 准教授 (90250422)

Co-Investigator(Kenkyū-buntansha) HIDA Kyoko  北海道大学, 歯学研究科, 特任准教授 (40399952)
HIDA Yasuhiro  北海道大学, 大学病院, 講師 (30399919)
NONOMURA Katsuya  北海道大学, 大学院医学研究科, 特任教 授 (60113750)
Project Period (FY) 2011 – 2013
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2013: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Keywords腎癌 / バイオマーカー / 腫瘍血管内皮細胞 / 腫瘍血管内皮 / 循環血管内皮 / 転移 / 腎臓がん / 末梢循環主要血管内皮細胞 / 転移性腎癌 / 診断・治療バイオマーカー
Research Abstract

We identified several markers (PTGIR, Biglycan, LOX, CXCR7 etc. ) highly expressed in mouse tumor endothelial cell (TEC) by real-time PCR of circulating endothelial cell (CEC) in metastatic renal cell carcinoma(RCC). We isolated human TEC from human RCC tissues and human normal endothelial cell (NEC) from normal kidney tissues of six patients. PTGIR, Biglycan, LOX and CXCR7 expression levels were significantly higher in human TEC than in human NEC for all paired cases. These results suggested that CEC might be a useful biomarker of RCC.

Report

(4 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • 2011 Research-status Report
  • Research Products

    (38 results)

All 2013 2012 2011

All Journal Article (22 results) (of which Peer Reviewed: 16 results) Presentation (15 results) Book (1 results)

  • [Journal Article] Chromophobe renal cell carcinoma, oncocytic variant : A proposal of a new variant and a critical diagnostic pitfall in diagnosing renal oncocytic tumors2013

    • Author(s)
      Kuroda N, Tanaka A, Yamaguchi T, Kasahara K, Naruse K, Yamada Y, Chikai-Kubota K, Shinohara N, Nagashima Y, Mikami S, Oya M, Hamashima T, Michal M, Hes O
    • Journal Title

      Med. Mol. Morphol

      Volume: 46(1) Pages: 49-55

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy of ATP-competitive inhibitors of mTORC2 on regulation of E-cadherin via HIF-2αin the renal cell carcinoma cell line 786-O2013

    • Author(s)
      Maru S, Ishigaki Y, Shinohara N, Takata T, Tomosugi N, Nonomura K
    • Journal Title

      J. Urol

      Volume: 189(5) Pages: 1921-1929

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma2013

    • Author(s)
      Akiyama K, Ohga N, Maishi N, Hida Y, Kitayama K, Kawamoto T, Osawa T, Suzuki Y, Shinohara N, Nonomura K, Shindoh M, Hida K
    • Journal Title

      Pathol. Int

      Volume: 63(1) Pages: 37-44

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy and safey of axitinib versus sorafenib in metastatic renal cell carcinoma : subgroup analysis of Japanese patients from a randomized phase 3 AXIS trial2013

    • Author(s)
      Ueda T, Uemura H, Tomita Y, Tsukamoto T, Kanayama H, Shinohara N, Tarazl J, Chen C, Kim S, Ozono S, Naito S, Akaza H
    • Journal Title

      Jpn. J. Clin. Oncol

      Volume: 43(6) Pages: 616-628

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Lysyl oxidase secreted by tumor endothelial cells promotes angiogenesis and metastasis2013

    • Author(s)
      Osawa T, Ohga N, Hida Y, Kitayama K, Akiyama K, Onodera Y, Fujita M, Shinohara N, Nonomura K, Shindoh M, Hida K
    • Journal Title

      Br J Cancer

      Volume: 109(8) Pages: 2237-2247

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Chromophobe renal cell carcinoma, oncocytic variant : a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors2013

    • Author(s)
      Kuroda N, Nagashima Y et al
    • Journal Title

      Med Mol Morphol

      Volume: 46(1) Issue: 1 Pages: 49-55

    • DOI

      10.1007/s00795-012-0007-7

    • NAID

      10031171364

    • Related Report
      2013 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy of ATP-competitive inhibitors of mTORC2 on regulation of E-cadherin via HIF-2α in the renal cell carcinoma cell line 786-O.2013

    • Author(s)
      Shinohara N,
    • Journal Title

      J. Urol.

      Volume: 189(5) Issue: 5 Pages: 1921-1929

    • DOI

      10.1016/j.juro.2012.11.010

    • Related Report
      2013 Annual Research Report
  • [Journal Article] The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma2013

    • Author(s)
      Akiyama K., Ohga N., Maishi N., Hida Y., Kitayama K., Kawamoto T., Osawa T., Suzuki Y., Shinohara N., Nonomura K., Shindoh M., Hida K.
    • Journal Title

      Pathol. Int.

      Volume: 63(1) Issue: 1 Pages: 37-44

    • DOI

      10.1111/pin.12031

    • Related Report
      2013 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy and safey of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from a randomized phase 3 AXIS trial.2013

    • Author(s)
      Shinohara N,
    • Journal Title

      Jpn. J. Clin. Oncol.

      Volume: 43(6) Pages: 616-628

    • Related Report
      2013 Annual Research Report
  • [Journal Article] Lysyl oxidase secreted by tumor endothelial cells promotes angiogenesis and metastasis.2013

    • Author(s)
      Shinohara N,
    • Journal Title

      Br J Cancer

      Volume: 109(8) Pages: 2237-2247

    • Related Report
      2013 Annual Research Report
  • [Journal Article] 標準治療となった個別化治療泌尿器腫瘍に対する個別化治療-転移性腎細胞がん-2012

    • Author(s)
      篠原信雄
    • Journal Title

      腫瘍内科9

      Volume: 6 Pages: 36-43

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Interferson-α-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situ.2012

    • Author(s)
      篠原信雄
    • Journal Title

      Jpn J Clin Oncol.

      Volume: 42 Pages: 113-119

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma.2012

    • Author(s)
      篠原信雄
    • Journal Title

      Cancer Sci

      Volume: 103(9) Pages: 1695-1700

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Renal cell carcinoma-response criteria of molecular targeted therapy and the timing of sequential drugs in patients with advanced renal cell carcinoma.2012

    • Author(s)
      篠原信雄
    • Journal Title

      Gan To Kagaku Ryoho

      Volume: 39(10) Pages: 1462-1466

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] 腎癌の診断の変遷2012

    • Author(s)
      篠原信雄
    • Journal Title

      泌尿器外科

      Volume: 25 Pages: 159-164

    • Related Report
      2012 Research-status Report
  • [Journal Article] 未治療・low-intermediate risk進行性腎癌において免疫療法と分子標的治療のどちらが最適か?2012

    • Author(s)
      篠原信雄
    • Journal Title

      臨床泌尿器科

      Volume: 66 Pages: 11-16

    • Related Report
      2012 Research-status Report
  • [Journal Article] 標準治療となった個別化治療 泌尿器腫瘍に対する個別化治療-転移性腎細胞がん-2012

    • Author(s)
      篠原信雄
    • Journal Title

      腫瘍内科

      Volume: 9 Pages: 36-43

    • Related Report
      2012 Research-status Report
  • [Journal Article] Interferon-α-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situ2012

    • Author(s)
      hinohara N, Abe T, Sazawa A, et al
    • Journal Title

      Jpn J Clin Oncol

      Volume: 42 Issue: 2 Pages: 113-119

    • DOI

      10.1093/jjco/hyr176

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Long-term survival in apatient with node-positive pdult-onset Xp11.2 translocation renal cell carcinoma.2011

    • Author(s)
      Aoyagi T, Shinohara N, Kubota K, Kuroda N, Nonomura K.
    • Journal Title

      Urol Int

      Volume: 86 Issue: 4 Pages: 487-490

    • DOI

      10.1159/000323866

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Outcome of regional lymph node dissection in conjunction with laparoscopic nephroureterectomy for urothelial carcinoma of the upper urinary tract2011

    • Author(s)
      Abe T, Harabayashi T, Shinohara N, et al.
    • Journal Title

      Journal of Endourology

      Volume: 25 Issue: 5 Pages: 803-807

    • DOI

      10.1089/end.2010.0480

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Is memorial sloan-kettering cancer center risk classification appropriate for japanese patients with metastatic renal cell carcinoma in the cytokine era?2011

    • Author(s)
      Shinohara N, Abe T, Mochizuki T, Kashiwagi A, Kanagawa K, et al.
    • Journal Title

      Urologic Oncology「掲載確定」

      Volume: 未

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] The incidence and the mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma.2011

    • Author(s)
      Shinohara N, Takahashi M, Kamishima T, Ikushima H, Otsuka N, Ishizu A, Shimizu C, Kanayama H, Nonomura K.
    • Journal Title

      Br J Cancer

      Volume: 104 Issue: 2 Pages: 241-247

    • DOI

      10.1038/sj.bjc.6606029

    • NAID

      120003169038

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Presentation] A randomized multi-center phase II trial on efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma2013

    • Author(s)
      Shinohara N, Nonomura N, Kimura G, Eto M, Minami H, Yamazaki N, Naito S
    • Organizer
      The 49^<th> ASCO Annual meeting
    • Place of Presentation
      Chicago
    • Related Report
      2013 Final Research Report
  • [Presentation] A randomized multi-center phase II trial on efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma.2013

    • Author(s)
      Shinohara N
    • Organizer
      The 49th ASCO Annual meeting Chicago 2013.
    • Place of Presentation
      Chicago USA lllinois
    • Related Report
      2013 Annual Research Report
  • [Presentation] Regional differences in the approach to systemic therapy for metastatic renal cell carcinoma2012

    • Author(s)
      Shinohara N
    • Organizer
      The Asian approach, 32th SIU annual meeting
    • Place of Presentation
      in FUKUOKA, Fukuoka
    • Related Report
      2013 Final Research Report
  • [Presentation] 日本における進行性腎細胞がん治療の現状 -Urologistの工夫-2012

    • Author(s)
      篠原信雄
    • Organizer
      第100回日本泌尿器科学会総会
    • Place of Presentation
      パシフィコ横浜(神奈川)
    • Related Report
      2012 Research-status Report
  • [Presentation] 分子標的療法の導入は有転移腎がんの予後を改善したか?2012

    • Author(s)
      篠原信雄
    • Organizer
      第100回日本泌尿器科学会総会
    • Place of Presentation
      パシフィコ横浜(神奈川)
    • Related Report
      2012 Research-status Report
  • [Presentation] 2nd TURBT時代の筋層非浸潤性膀胱癌治療2012

    • Author(s)
      篠原信雄
    • Organizer
      第77回日本泌尿器科学会東部総会
    • Place of Presentation
      東京ドームホテル(東京)
    • Related Report
      2012 Research-status Report
  • [Presentation] 原則としてすべての腫瘍マーカーが陰性化した時点で 残存腫瘍の切除術を考慮するが例外はありうるか?2012

    • Author(s)
      篠原信雄
    • Organizer
      第50回日本癌治療学会
    • Place of Presentation
      パシフィコ横浜(神奈川)
    • Related Report
      2012 Research-status Report
  • [Presentation] Risk classification to predict survival after cytoreductive nephrectomy in2012

    • Author(s)
      篠原信雄
    • Organizer
      107th American Urological Association (AUA)
    • Place of Presentation
      Georgia World Congress Center(Atlanta, USA)
    • Related Report
      2012 Research-status Report
  • [Presentation] Sorafenib-associated Hand-Foot Skin Reaction: How to deal with this adverse event?2012

    • Author(s)
      篠原信雄
    • Organizer
      4th Congress of the World Union of Wound Healing Societies
    • Place of Presentation
      パシフィコ横浜(神奈川)
    • Related Report
      2012 Research-status Report
  • [Presentation] Castration-resistant prostate cancer =Current status and future perspectives in Japan=2012

    • Author(s)
      篠原信雄
    • Organizer
      29th Japan-Korea Urological Congress
    • Place of Presentation
      パークホテル(鹿児島)
    • Related Report
      2012 Research-status Report
  • [Presentation] Regional differences in the Approach to Systemic Therapy for Metastatic Renal Cell Carcinoma: The Asian Approach2012

    • Author(s)
      篠原信雄
    • Organizer
      32nd Congress of the Societe Internationale d’Urologie (SIU)
    • Place of Presentation
      福岡インターナショナルコングレスセンター(福岡)
    • Related Report
      2012 Research-status Report
  • [Presentation] Treatment strategy of RCC in Japan=prognostic factor=2012

    • Author(s)
      篠原信雄
    • Organizer
      32nd Congress of the Societe Internationale d’Urologie (SIU)
    • Place of Presentation
      福岡インターナショナルコングレスセンター(福岡)
    • Related Report
      2012 Research-status Report
  • [Presentation] The role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.2011

    • Author(s)
      Shinohara N.
    • Organizer
      JUA/AUA Joint meeting in AUA 2011 (Symposium)
    • Place of Presentation
      Washinton Convention Center (USA)
    • Related Report
      2011 Research-status Report
  • [Presentation] A randomized multi-center phase II trial on efficacy of high-slip skin care pad for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma.2011

    • Author(s)
      Shinohara N.
    • Organizer
      47th ASCO annual meeting 2011 (Special session)
    • Place of Presentation
      MCCORMICK PLACE (USA)
    • Related Report
      2011 Research-status Report
  • [Presentation] The role of metastasectomy for patients with metastatic urological cancer.2011

    • Author(s)
      Shinohara N.
    • Organizer
      8th Korea-Japan Urological Congress (Invited Speaker)(招待講演)
    • Place of Presentation
      RAMADA PLAZA SUWON (Korea)
    • Related Report
      2011 Research-status Report
  • [Book] フォン・ヒッペル・リンドウ(VHL)病診療ガイドライン -腎癌-. VHL病診療ガイドライン2012

    • Author(s)
      篠原信雄
    • Publisher
      中外医学社
    • Related Report
      2012 Research-status Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi